You don’t need to be a sleep specialist. You just need the right guide.

You don’t need to be. Most pharmacists had one lecture on sleep at university and haven’t thought about it since. That’s normal, and that’s exactly the gap SleepNav is designed to fill.

The guided consultation walks you through every question you need to ask and tells you why you’re asking it. Safety checks run automatically. The clinical logic is built on validated instruments and expert consensus – you apply it, you don’t need to memorise it.

Your job is the bit no system can do: talk to the patient, use your professional judgement, and deliver the consultation with the care and attention that only a pharmacist in the room can provide. SleepNav handles the clinical structure. You handle the patient.

The BSPSS offers accredited training if you want to go deeper. But you can start delivering consultations from day one.

SleepNav's triage logic is built on published clinical protocols and validated screening instruments. The system covers sleep-related breathing disorders, insomnia management, and medication safety for older adults. Each pathway applies structured risk assessment with appropriate safety gates.

The system is being aligned with internationally agreed scope-of-practice standards through an ongoing Delphi consensus study with 54 expert panellists. Every decision node in the system maps to a specific evidence source or consensus statement.

SleepNav is developed and maintained by Adrian Zacher of Snorer.com Ltd, with 30 years of experience in the sleep industry.

SleepNav was designed from the ground up to operate without patient personal data. No names, no dates of birth, no NHS numbers, no contact details. The system processes clinical variables – screening responses, risk scores, symptom profiles – without any identifier that could link them to an individual patient.

No patient personal data is collected, which means no DPIA is required for patient data. No data processing agreement between you and us for patient information. No Information Governance approval from your ICB. No DSPT assessment for the system. No data breach notification risk for patient information. No data subject access request obligations for patients.

You can deploy SleepNav in your pharmacy without seeking anyone's permission beyond your own. The clinical record stays in your PMR where it belongs. SleepNav provides the decision support layer. It doesn’t need to know who the patient is.

Some patients avoid seeking help for sleep problems – not because they don't recognise the symptoms, but because they fear the consequences of a diagnosis. Vocational drivers, pilots, and safety-critical occupation workers know that a diagnosis of obstructive sleep apnoea can trigger licence reviews, occupational health referrals, and fitness-to-practise assessments. For many, the perceived risk to their livelihood outweighs the perceived benefit of treatment.

This creates a genuine clinical problem. Untreated OSA carries significant cardiovascular, metabolic, and accident risk. The patients who most need screening are often the ones least likely to present to their GP.

SleepNav's privacy architecture changes this equation. No patient-identifiable data enters the system, so there is no record that could be disclosed, requested, or subject to witness summons. The patient can explore their sleep problem without creating a record that could follow them into the workplace. The screening happens in person at the pharmacy counter, the output code is shown on screen and spoken aloud, and the clinical record stays in the pharmacist's PMR – exactly where it belongs, under normal pharmacy record-keeping rules.

This isn't a workaround. It's a design principle. By removing the data trail that patients fear, SleepNav enables clinical access for a population that would otherwise remain unscreened and untreated. The pharmacist can have an honest conversation about occupational implications, explain the licensing framework, and support the patient in making an informed decision – rather than never seeing them at all.

£10 per month, plus £8 per patient screening. No annual contract, no setup cost, no minimum commitment. Cancel any time.

Every new pharmacy gets a 14-day free trial with full access to all features – no charges at all during the trial period. After your trial, we include 2 free patient screenings in your first month. Billing is via Stripe. You'll see usage, costs, and downloadable PDF invoices in your dashboard.

The subscription covers your pharmacy site, not individual pharmacists. Whether you have one regular pharmacist or a rotating locum rota, everyone on your team can use SleepNav under a single subscription. One site, one subscription.

If you're charging patients for a sleep consultation (which the revenue calculator can help you model), the £8 screening cost is a fraction of consultation revenue. If you're offering the service under an NHS contract, subscription and screening costs are demonstrable cost lines with documented clinical output.

Minimum requirements: A private consultation space that accommodates the patient and a partner. A computer, laptop, or tablet with a browser. A pharmacist (and optionally a technician) who's completed BSPSS-accredited sleep training. That's the baseline. BSPSS-accredited sleep training is completely free. You can enrol at bspss.org.

For the patient screening: An iPad or tablet ideally on your pharmacy counter running the SleepNav patient app. Patients complete the two-minute screen independently. The Zone 1 Deployment Guide walks you through the full setup in about 15 minutes.

Service and referral pathways: You'll need a home sleep apnoea test pathway (you can offer this as a pharmacy service or refer) and a GP escalation pathway, both straightforward to establish. For dental referrals (mandibular advancement devices), we'll help you build your local dental network and the system includes a built-in referral directory to manage it. The Service Readiness Checklist walks you through all of this.

Multi-site pharmacies: Each pharmacy site requires its own SleepNav subscription. If you operate multiple branches, each site registers independently. Group billing options may be available – book a call to discuss.

Snorer.com Ltd is registered with the MHRA as a manufacturer of Class I medical devices (GMDN 61087). SleepNav is classified as clinical decision support software. It supports pharmacist decision-making without making autonomous clinical decisions. The pharmacist retains full clinical authority at every point.

The system does not diagnose sleep disorders. It does not prescribe treatment. It provides structured, evidence-based guidance that a qualified pharmacist applies within the context of their professional consultation.